Related Experiment Video
Updated: Feb 14, 2026

Free Radicals in Chemical Biology: from Chemical Behavior to Biomarker Development
Published on: April 15, 2013
Transforming Biomarker Development with Exceptional Responders
Philip Jonsson1, Barry S Taylor2
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract:
Curative therapy for cancer patients with advanced-stage disease remains elusive. While rare outlier responses to anticancer therapies exist, barriers limit our understanding of the molecular and genetic basis of such profound, life-altering responses. Here, we describe how phenotype-to-genotype studies are elucidating the molecular underpinnings of outlier responses and informing strategies to extend such unprecedented sensitivity to broader molecularly defined patient populations.
Insights
Understanding rare outlier responses in advanced cancer is key. Phenotype-to-genotype studies reveal the molecular basis, aiming to extend these profound cancer therapy benefits to more patients.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Curative treatment for advanced-stage cancer remains a significant challenge.
- Rare instances of exceptional responses to anticancer therapies offer potential insights.
- Understanding the molecular and genetic drivers of these outlier responses is limited.
Purpose of the Study:
- To investigate the molecular underpinnings of outlier responses to anticancer therapies.
- To leverage phenotype-to-genotype correlations for deeper understanding.
- To inform strategies for extending exceptional treatment sensitivity to a wider patient group.
Main Methods:
- Utilizing phenotype-to-genotype studies.
- Analyzing molecular and genetic data from patients with outlier responses.
- Correlating clinical observations with genomic profiles.
Main Results:
- Phenotype-to-genotype studies are successfully elucidating the molecular basis of outlier anticancer therapy responses.
- These studies provide a framework for understanding the genetic factors contributing to profound treatment sensitivity.
- Identified molecular underpinnings offer potential targets for therapeutic development.
Conclusions:
- Phenotype-to-genotype analysis is a powerful approach to unraveling the biology of exceptional cancer treatment responses.
- This research informs the development of novel therapeutic strategies.
- The goal is to translate insights from outlier responders to benefit broader patient populations with advanced cancer.
Related Concept Videos
Exceptions to the Octet Rule
Bacterial Transformation
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Transformers
The iron core has a substantial relative permeability. Therefore, the magnetic field lines generated due to the current in one winding are almost entirely confined within the core, such that the same magnetic flux permeates each turn of both...
Transformation
Transformations of Functions I
The Ideal Transformer
Ampere's Law forms the basis of understanding the magnetic field within the transformer. It states that the integral of the magnetic field intensity's tangential...

